Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Author Correction: Mutational signatures reveal the role of RAD52 in p53-independent p21-driven genomic instability.

ABSTRACT:

SUBMITTER: Galanos P

PROVIDER: S-EPMC9052693 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Author Correction: Mutational signatures reveal the role of RAD52 in p53-independent p21-driven genomic instability.

Galanos Panagiotis P Pappas George G Polyzos Alexander A Kotsinas Athanassios A Svolaki Ioanna I Giakoumakis Nickolaos N NN Glytsou Christina C Pateras Ioannis S IS Swain Umakanta U Souliotis Vassilis L VL Georgakilas Alexandros G AG Geacintov Nicholas N Scorrano Luca L Lukas Claudia C Lukas Jiri J Livneh Zvi Z Lygerou Zoi Z Chowdhury Dipanjan D Sørensen Claus Storgaard CS Bartek Jiri J Gorgoulis Vassilis G VG

Genome biology 20220428 1

PMID: 35484586

Similar Datasets

Mutational signatures reveal the role of RAD52 in p53-independent p21-driven genomic instability.

Project description:BackgroundGenomic instability promotes evolution and heterogeneity of tumors. Unraveling its mechanistic basis is essential for the design of appropriate therapeutic strategies. In a previous study, we reported an unexpected oncogenic property of p21WAF1/Cip1, showing that its chronic expression in a p53-deficient environment causes genomic instability by deregulation of the replication licensing machinery.ResultsWe now demonstrate that p21WAF1/Cip1 can further fuel genomic instability by suppressing the repair capacity of low- and high-fidelity pathways that deal with nucleotide abnormalities. Consequently, fewer single nucleotide substitutions (SNSs) occur, while formation of highly deleterious DNA double-strand breaks (DSBs) is enhanced, crafting a characteristic mutational signature landscape. Guided by the mutational signatures formed, we find that the DSBs are repaired by Rad52-dependent break-induced replication (BIR) and single-strand annealing (SSA) repair pathways. Conversely, the error-free synthesis-dependent strand annealing (SDSA) repair route is deficient. Surprisingly, Rad52 is activated transcriptionally in an E2F1-dependent manner, rather than post-translationally as is common for DNA repair factor activation.ConclusionsOur results signify the importance of mutational signatures as guides to disclose the repair history leading to genomic instability. We unveil how chronic p21WAF1/Cip1 expression rewires the repair process and identifies Rad52 as a source of genomic instability and a candidate therapeutic target.

| S-EPMC5857109 | biostudies-literature

Author Correction: Tailings facility disclosures reveal stability risks.

Project description: Not available

| S-EPMC8175709 | biostudies-literature

Author Correction: Edgetic perturbation signatures represent known and novel cancer biomarkers.

Project description: Not available

| S-EPMC7864967 | biostudies-literature

Author Correction: Lkb1 suppresses amino acid-driven gluconeogenesis in the liver.

Project description: Not available

| S-EPMC7969603 | biostudies-literature

Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing.

Project description:The cyclin-dependent kinase inhibitor p21(WAF1/CIP1) (p21) is a cell-cycle checkpoint effector and inducer of senescence, regulated by p53. Yet, evidence suggests that p21 could also be oncogenic, through a mechanism that has so far remained obscure. We report that a subset of atypical cancerous cells strongly expressing p21 showed proliferation features. This occurred predominantly in p53-mutant human cancers, suggesting p53-independent upregulation of p21 selectively in more aggressive tumour cells. Multifaceted phenotypic and genomic analyses of p21-inducible, p53-null, cancerous and near-normal cellular models showed that after an initial senescence-like phase, a subpopulation of p21-expressing proliferating cells emerged, featuring increased genomic instability, aggressiveness and chemoresistance. Mechanistically, sustained p21 accumulation inhibited mainly the CRL4-CDT2 ubiquitin ligase, leading to deregulated origin licensing and replication stress. Collectively, our data reveal the tumour-promoting ability of p21 through deregulation of DNA replication licensing machinery-an unorthodox role to be considered in cancer treatment, since p21 responds to various stimuli including some chemotherapy drugs.

| S-EPMC6535144 | biostudies-literature

Author Correction: Cryo-EM structures of PAC1 receptor reveal ligand binding mechanism.

Project description:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

| S-EPMC7265381 | biostudies-literature

Chronic p53-independent p21 expression deregulates replication licensing, leading to genomic instability

Project description:P53 independent P21 expression deregulates replication licensing , leading to genomic instability

2016-05-17 | PXD004140 | Pride

Proteomic signatures associated with p53 mutational status in lung adenocarcinoma.

Project description:p53 is commonly mutated in lung adenocarcinoma. Mutant p53 loses wild-type function and some missense mutations further acquire oncogenic functions, while p53 wild-type may also induce pro-survival signaling. Therefore identification of signatures based on p53 mutational status has relevance to our understanding of p53 signaling pathways in cancer and identification of new therapeutic targets. To this end, we compared proteomic profiles of three cellular compartments (whole-cell extract, cell surface, and media) from 28 human lung adenocarcinoma cell lines that differ based on p53 mutational status. In total, 11,598, 11,569, and 9090 protein forms were identified in whole-cell extract, cell surface, and media, respectively. Bioinformatic analysis revealed that representative pathways associated with epithelial adhesion, immune and stromal cells, and mitochondrial function were highly significant in p53 missense mutations, p53 loss and wild-type p53 cell lines, respectively. Of note, mRNA levels of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1-?), a transcription coactivator that promotes mitochondrial oxidative phosphorylation and mitochondrial biogenesis, was substantially higher in p53 wild-type cell lines compared to either cell lines with p53 loss or with missense mutation. Small interfering RNA targeting PGC1-? inhibited cell proliferation in p53 wild-type cell lines, indicative of PGC1-? and its downstream molecules as potential therapeutic targets in p53 wild-type lung adenocarcinoma.

| S-EPMC4403731 | biostudies-literature

Author Correction: Microbial community dynamics and coexistence in a sulfide-driven phototrophic bloom.

Project description: Not available

| S-EPMC10064758 | biostudies-literature

INMAP overexpression inhibits cell proliferation, induces genomic instability and functions through p53/p21 pathways.

Project description:INMAP is a spindle protein that plays essential role for mitosis, by ensuring spindle and centromere integrality. The aim of this study was to investigate the relevant functions of INMAP for genomic stability and its functional pathway. We overexpressed INMAP in HeLa cells, resulting in growth inhibition in monolayer cell cultures, anchorage-independent growth in soft agar and xenograft growth in nude mice. In this system caused micronuclei (MNi) formation, chromosome distortion and γH2AX expression upregulation, suggesting DNA damage induction and genomic stability impairment. As a tumour biochemical marker, lactate dehydrogenase (LDH) isoenzymes were detected to evaluate cell metabolic activity, the results confirming that total activity of LDH, as well as that of its LDH5 isoform, is significantly decreased in INMAP-overexpressing HeLa cells. The levels of p53 and p21 were upregulated, and however, that of PCNA and Bcl-2, downregulated. Indirect immunofluorescence (IIF) and coimmunoprecipitation (CoIP) analyses revealed the interaction between INMAP and p21. These results suggest that INMAP might function through p53/p21 pathways.

| S-EPMC4312054 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data